For the BED patients, there was a highly significant and steady decrease in the 4-week frequency of binge eating episodes, the 4-week frequency of binge eating days, EDE-Q scores, and QIDS-SR 16 score over the course of treatment ( P < 0.001 for all measures), except for the EDE-Q Restraint score ( P = 0.361).
← all excerpts
Polaprezinc (Zinc-L-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions: A Pilot Study.
1
—
—